Cell and gene therapy patents: What’s accelerating, what’s lagging behind

Neutral

AI Analysis

Summary

Cell and gene therapy patent filings decreased 25% through May 2026, while patent grant ratios increased. The article analyzes IP concentration across diseases, assignees, and technologies in the sector.

Importance:2/10

Sentiment:

0.00

cell and gene therapypatent filingsintellectual propertypatent grantsmarket analysis

Read the original article

Published by Pharmaceutical Technology on July 2, 2026 12:04 PM

Read Original